These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

123 related items for PubMed ID: 37517243

  • 1. Copeptin response to panic provocation with CO2 in healthy adults.
    Müller JC, Walter C, Leibold N, Wiedemann K, Kellner M, Demiralay C.
    J Psychiatr Res; 2023 Sep; 165():225-232. PubMed ID: 37517243
    [Abstract] [Full Text] [Related]

  • 2. Copeptin - A potential endocrine surrogate marker of CCK-4-induced panic symptoms?
    Demiralay C, Agorastos A, Yassouridis A, Jahn H, Wiedemann K, Kellner M.
    Psychoneuroendocrinology; 2017 Feb; 76():14-18. PubMed ID: 27871026
    [Abstract] [Full Text] [Related]

  • 3. Effects of the cortisol synthesis inhibitor metyrapone on the response to carbon dioxide challenge in panic disorder.
    Belgorodsky A, Knyazhansky L, Loewenthal U, Arbelle J, Cohen H, Benjamin J.
    Depress Anxiety; 2005 Feb; 21(3):143-8. PubMed ID: 16001448
    [Abstract] [Full Text] [Related]

  • 4. CO2 challenge induced HPA axis activation in panic.
    van Duinen MA, Schruers KR, Maes M, Griez EJ.
    Int J Neuropsychopharmacol; 2007 Dec; 10(6):797-804. PubMed ID: 17076937
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. CO2 challenge results in hypothalamic-pituitary-adrenal activation in healthy volunteers.
    van Duinen MA, Schruers KR, Maes M, Griez EJ.
    J Psychopharmacol; 2005 May; 19(3):243-7. PubMed ID: 15888509
    [Abstract] [Full Text] [Related]

  • 7. Panic induced by carbon dioxide inhalation and lack of hypothalamic-pituitary-adrenal axis activation.
    Sinha SS, Coplan JD, Pine DS, Martinez JA, Klein DF, Gorman JM.
    Psychiatry Res; 1999 May 31; 86(2):93-8. PubMed ID: 10397411
    [Abstract] [Full Text] [Related]

  • 8. [Anxiety, panic and the hypothalamic-pituitary-adrenal axis].
    Graeff FG.
    Braz J Psychiatry; 2007 May 31; 29 Suppl 1():S3-6. PubMed ID: 17546345
    [Abstract] [Full Text] [Related]

  • 9. Effects of alprazolam on cholecystokinin-tetrapeptide-induced panic and hypothalamic-pituitary-adrenal-axis activity: a placebo-controlled study.
    Zwanzger P, Eser D, Aicher S, Schüle C, Baghai TC, Padberg F, Ella R, Möller HJ, Rupprecht R.
    Neuropsychopharmacology; 2003 May 31; 28(5):979-84. PubMed ID: 12700707
    [Abstract] [Full Text] [Related]

  • 10. Central noradrenaline transporter availability is linked with HPA axis responsiveness and copeptin in human obesity and non-obese controls.
    Schinke C, Hesse S, Rullmann M, Becker GA, Luthardt J, Zientek F, Patt M, Stoppe M, Schmidt E, Meyer K, Meyer PM, Orthgieß J, Blüher M, Kratzsch J, Ding YS, Then Bergh F, Sabri O.
    Stress; 2019 Jan 31; 22(1):93-102. PubMed ID: 30369292
    [Abstract] [Full Text] [Related]

  • 11. Hypothalamic-pituitary-adrenal axis activity in panic disorder. 24-hour secretion of corticotropin and cortisol.
    Abelson JL, Curtis GC.
    Arch Gen Psychiatry; 1996 Apr 31; 53(4):323-31. PubMed ID: 8634010
    [Abstract] [Full Text] [Related]

  • 12. Pituitary-adrenal axis hormones in early-onset versus late-onset panic disorder.
    Masdrakis VG, Legaki EM, Papageorgiou C, Markianos M.
    Int J Psychiatry Clin Pract; 2022 Mar 31; 26(1):72-78. PubMed ID: 33043745
    [Abstract] [Full Text] [Related]

  • 13. HPA axis activity in patients with panic disorder: review and synthesis of four studies.
    Abelson JL, Khan S, Liberzon I, Young EA.
    Depress Anxiety; 2007 Mar 31; 24(1):66-76. PubMed ID: 16845643
    [Abstract] [Full Text] [Related]

  • 14. Dissociation between ACTH and cortisol response in DEX-CRH test in patients with panic disorder.
    Petrowski K, Wintermann GB, Kirschbaum C, Bornstein SR.
    Psychoneuroendocrinology; 2012 Aug 31; 37(8):1199-208. PubMed ID: 22277728
    [Abstract] [Full Text] [Related]

  • 15. Cognitive modulation of the endocrine stress response to a pharmacological challenge in normal and panic disorder subjects.
    Abelson JL, Liberzon I, Young EA, Khan S.
    Arch Gen Psychiatry; 2005 Jun 31; 62(6):668-75. PubMed ID: 15939844
    [Abstract] [Full Text] [Related]

  • 16. Megestrol attenuates the hormonal response to CCK-4-induced panic attacks.
    Raedler TJ, Jahn H, Goedeken B, Gescher DM, Kellner M, Wiedemann K.
    Depress Anxiety; 2006 Jun 31; 23(3):139-44. PubMed ID: 16470820
    [Abstract] [Full Text] [Related]

  • 17. Salivary cortisol in panic: are males more vulnerable?
    van Duinen MA, Schruers KR, Jaegers E, Maes M, Griez EJ.
    Neuro Endocrinol Lett; 2004 Oct 31; 25(5):386-90. PubMed ID: 15580175
    [Abstract] [Full Text] [Related]

  • 18. A striking pattern of cortisol non-responsiveness to psychosocial stress in patients with panic disorder with concurrent normal cortisol awakening responses.
    Petrowski K, Herold U, Joraschky P, Wittchen HU, Kirschbaum C.
    Psychoneuroendocrinology; 2010 Apr 31; 35(3):414-21. PubMed ID: 19913360
    [Abstract] [Full Text] [Related]

  • 19. Effects of antidepressant on FKBP51 mRNA expression and neuroendocrine hormones in patients with panic disorder.
    Zou Z, Huang Y, Maes M, Wang J, He Y, Min W, Zhou B.
    BMC Psychiatry; 2024 Apr 10; 24(1):269. PubMed ID: 38600448
    [Abstract] [Full Text] [Related]

  • 20. Does sex hormone treatment reverse the sex-dependent stress regulation? A longitudinal study on hypothalamus-pituitary-adrenal (HPA) axis activity in transgender individuals.
    Fuss J, Claro L, Ising M, Biedermann SV, Wiedemann K, Stalla GK, Briken P, Auer MK.
    Psychoneuroendocrinology; 2019 Jun 10; 104():228-237. PubMed ID: 30897530
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.